Exact Mass: 400.2396
Exact Mass Matches: 400.2396
Found 177 metabolites which its exact mass value is equals to given mass value 400.2396
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Nocloprost
MG(5-iso PGF2VI/0:0/0:0)
MG(5-iso PGF2VI/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/5-iso PGF2VI/0:0)
MG(0:0/5-iso PGF2VI/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
10-O-beta-D-glucopyranosideoplopanone|oplopanone-8-O-beta-D-glucopyranoside
1-O-isopropyl-6-O-(5,9-dimethyl-2,8-decadienoyl)-beta-D-glucopyranoside|citrusoside A
1(R),4beta-dihydroxy-trans-eudesm-6-ene-1-O-beta-D-glucopyranoside
3beta,11-dihydroxy-drim-8(12)-en-11-O-beta-D-glucopyranoside|xianglinmaojueside A
3beta-[(beta-D-glucopyranosyl)oxy]eudesm-4(14)-en-11-ol
16-methoxy-1-propionyl-aspidospermidine-17,21-diol|16-methoxy-limaspermine|3-Methoxy-limaspermin
1alpha,6beta-dihydroxy-5,10-bis-epi-eudesm-4(15)-ene-6-O-beta-D-glucopyranoside|funingensin A
7-drimen-3beta-,11-diol 3-O-beta-D-glucopyranoside
3alpha-hydroxypatchoulol 3-O-beta-D-glucopyranoside
(2R*,5S*,7R*,10S*)-7-hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane
1beta-hydroxy-3-oxo-4beta,5alpha,7alpha-H-eudesmane 11-O-alpha-L-rhamnopyranoside
2,7,11-trihydroxybisabola-1(15),9-diene 7-beta-D-fucopyranoside
2,7,10-trihydroxybisabola-1(15),11-diene 7-beta-D-fucopyranoside
(5S,6E)-5-beta-D-glucopyranosyloxy-3-hydroxy-3,7,11-trimethyldodeca-1,6,10-triene|amarantholidoside III
3beta,11-dihydroxy-drim-8(12)-en-3-O-beta-D-glucopyranoside|xianglinmaojueside B
1beta-(beta-D-glucopyranosyl)oxy-6alpha-hydroxyeudesman-4(15)-ene|1??-D-Glucopyranosyloxy-6??-hydroxyeudesman-4(15)-ene
1(R),4beta-dihydroxy-trans-eudesm-7-ene-1-O-beta-D-glucopyranoside|oplodiol 1-O-beta-D-glucopyranoside
11,14-dihydroxy-drim-8(12)-en-11-O-beta-D-glucopyranoside|xianglinmaojueside C
phenyl-acetic acid 9-hydroxymethyl-7-(6-oxo-piperidin-2-yl)-octahydro-quinolizin-2-yl ester
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000846078]
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based: Match]
Ala Ile Pro Thr
Ala Ile Thr Pro
Ala Leu Pro Thr
Ala Leu Thr Pro
Ala Pro Ile Thr
Ala Pro Leu Thr
Ala Pro Thr Ile
Ala Pro Thr Leu
Ala Thr Ile Pro
Ala Thr Leu Pro
Ala Thr Pro Ile
Ala Thr Pro Leu
Ile Ala Pro Thr
Ile Ala Thr Pro
Ile Pro Ala Thr
Ile Pro Thr Ala
Ile Thr Ala Pro
Ile Thr Pro Ala
Leu Ala Pro Thr
Leu Ala Thr Pro
Leu Pro Ala Thr
Leu Pro Thr Ala
Leu Thr Ala Pro
Leu Thr Pro Ala
Pro Ala Ile Thr
Pro Ala Leu Thr
Pro Ala Thr Ile
Pro Ala Thr Leu
Pro Ile Ala Thr
Pro Ile Thr Ala
Pro Leu Ala Thr
Pro Leu Thr Ala
Pro Ser Val Val
Pro Thr Ala Ile
Pro Thr Ala Leu
Pro Thr Ile Ala
Pro Thr Leu Ala
Pro Val Ser Val
Pro Val Val Ser
Ser Pro Val Val
Ser Val Pro Val
Ser Val Val Pro
Thr Ala Ile Pro
Thr Ala Leu Pro
Thr Ala Pro Ile
Thr Ala Pro Leu
Thr Ile Ala Pro
Thr Ile Pro Ala
Thr Leu Ala Pro
Thr Leu Pro Ala
Thr Pro Ala Ile
Thr Pro Ala Leu
Thr Pro Ile Ala
Thr Pro Leu Ala
Val Pro Ser Val
Val Pro Val Ser
Val Ser Pro Val
Val Ser Val Pro
Val Val Pro Ser
Val Val Ser Pro
Amantadine sulfate
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent C93038 - Cation Channel Blocker
Ala-Leu-Thr-Pro
A tetrapeptide composed of L-alanine, L-leucine, L-threonine, and L-proline units joined in sequence.
1-cyclopentyl-1-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-3-(2-oxolanylmethyl)thiourea
2,4-dioxo-3-pentyl-N-[3-(1-piperidinyl)propyl]-1H-quinazoline-7-carboxamide
rel-(2R,5S,7R,10S)-7-Hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane
A natural product found in Carthamus oxyacantha.
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
2-[(5-hydroxy-2-isopropyl-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2r)-2-[(2r,5s)-5-[(2s)-2-{[(2s)-2-[(2s,5r)-5-[(2r)-2-hydroxypropyl]oxolan-2-yl]propanoyl]oxy}butyl]oxolan-2-yl]propanoic acid
(2s,3r,4s,5r,6r)-2-({2-[(2r,5r,7r,10r)-7-hydroperoxy-10-methyl-6-methylidenespiro[4.5]decan-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol
2-(hydroxymethyl)-6-{[5-(hydroxymethyl)-1,1,4a-trimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl]oxy}oxane-3,4,5-triol
(2r,3r,4s,5r,6r)-2-{[(1s,4s,4as,8as)-4-hydroxy-4,8a-dimethyl-6-(propan-2-ylidene)-hexahydro-1h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r)-2-[(2r,5s)-5-[(2s)-2-{[(2s)-2-[(2s,5r)-5-[(2r)-2-hydroxybutyl]oxolan-2-yl]propanoyl]oxy}propyl]oxolan-2-yl]propanoic acid
(2r,3r,4s,5s,6r)-2-{[(1ar,3as,4s,7s,7as,7br)-7-hydroxy-1,1,3a,7-tetramethyl-octahydrocyclopropa[a]naphthalen-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(1s,4s,4as,8as)-4-hydroxy-1,4a-dimethyl-7-(propan-2-ylidene)-hexahydro-2h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5r,6r)-2-{[(1s,4s,4as,8as)-4-hydroxy-1,4a-dimethyl-7-(propan-2-ylidene)-hexahydro-2h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
1β-d-glucopyranosyloxy-6α-hydroxy-eudesman-4(15)-ene
{"Ingredient_id": "HBIN002393","Ingredient_name": "1\u03b2-d-glucopyranosyloxy-6\u03b1-hydroxy-eudesman-4(15)-ene","Alias": "NA","Ingredient_formula": "C21H36O7","Ingredient_Smile": "CC(C)C1CCC2(C(CCC(=C)C2C1O)OC3C(C(C(C(O3)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8691","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
atractyloside c
{"Ingredient_id": "HBIN017303","Ingredient_name": "atractyloside c","Alias": "NA","Ingredient_formula": "C21H36O7","Ingredient_Smile": "CC12CCC(CC1C(=C)CC(C2)O)C(C)(C)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "400.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14420","TCMID_id": "1976","TCMSP_id": "NA","TCM_ID_id": "6491","PubChem_id": "101831401","DrugBank_id": "NA"}